News
Hims & Hers will begin offering generic semaglutide drugs in Canada next year after Novo Nordisk lost its exclusive patent ...
U.S. telehealth platform looks to take advantage of Ozempic patent expiring in January, while four manufacturers filed for ...
14h
Asianet Newsable on MSNHims & Hers Announces Plans To Expand Into Canada As Novo Nordisk’s Weight Loss Drug Patent ExpiresThe telehealth company stated that its entry to Canada will come as generic Semaglutide hits the market for the first time.
The federal government's investigation into a recall of Salmonella-contaminated brown cage-free and certified-organic eggs ...
4h
Khaleej Times on MSNUAE retail investors charged into EV, tech, and telehealth stocks in Q2 2025According to data from eToro, leading the list was telehealth platform, Hims & Hers Health, which surged 85 per cent in ...
Whether identifying as Republicans or Democrats, about 70% of adults surveyed say health insurers exert too much influence ...
Recently, the United States has witnessed an intense legal and commercial confrontation between major pharmaceutical ...
ExodusPoint burst onto the hedge fund scene in 2018 with the largest launch in history — raising $8.5 billion out of the gate — powered by institutional backing, an elite Wall Street pedigree, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results